期刊文献+

p21^(waf1)基因的克隆及在大肠杆菌中的高效表达 被引量:1

Cloning of p21~ ( waf1)gene and its high expression in E.coli JM109
下载PDF
导出
摘要 目的 :构建人 p2 1waf1 基因的原核表达载体并在大肠杆菌 JM10 9中高效表达。方法 :从人肝细胞中分离总 RNA,经逆转录多聚酶链反应 (RT- PCR)得到 p2 1waf1 全基因。用原核细胞表达载体构建了 p BV 2 2 0 / p2 1waf1 重组质粒 ,经 DNA测序确认后 ,将其转化到大肠杆菌 JM10 9进行表达、初步纯化。结果 :SDS- PAGE凝胶电泳分离显示在分子量 2 10 0 0处有一诱导蛋白带 ,薄层扫描显示表达产物在诱导 5 h时可达细菌总蛋白的 38% ,Westernblotting证明表达产物与抗人 P2 1waf1 单克隆抗体有特异性免疫反应。结论 :成功构建出 p2 1waf1 表达载体 ,诱导产生蛋白经检测证实为 P2 1waf1 蛋白。 Objective To construct the pronucleus expression vector of human p21~ waf1and express it in E.coli strain of JM109. Methods The total RNA was isolated from human hepatocytes, and p21~ waf1 was cloned by RT-PCR, the PCR product was ligated with PGEM-T vector and sequenced. Then the target sequence was inserted into an temperature-sensitive expression vector pBV220 and expressed in E.coli JM109.The recombinant protein was identified by immunoblot. Results DNA sequencing confirmed that the sequence of cloned p21~ waf1 was identical to the published sequence. The recombinant plasmid pBV220/p21~ waf1 was transformed into E.coli JM109 and over- expressed during 42℃ induction. After induction for 5 h, the expression products showed a high expression level of recombinant protein with 21 000, and was more than 38% of the total bacterial protein. Western blotting analysis indicated that the the recombinant protein could react specifically with anti-P21~ waf1 antibody. Conclusion The p21~ waf1 expression vector is constructed successfully, and the induced-protein is confirmed as P21~ waf1 protein by detection.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2005年第2期209-212,共4页 Journal of Jilin University:Medicine Edition
基金 卫生部临床学科重点科研项目资助课题 (2 0 0 1314 5 ) 吉林省科技厅重点科研项目资助课题 (2 0 0 2 0 4 0 3) 吉林大学创新基金资助课题 (2 0 0 2年 ) 吉林大学临床医疗新技术新疗法 (2 0 0 10 3)
关键词 原癌基因蛋白质p21(ras) 克隆 分子 基因表达 proto-oncogene protein p21 (ras) cloning, molecular gene expression
  • 相关文献

参考文献9

  • 1Wang ZL, SuZZ, Fisher PB, et al. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21waf1/tip1/mda6 in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells [J]. Exp Cell Res, 1998, 244 (1): 105-116.
  • 2SambrookJ FritschEF ManiztisTC.分子克隆实验指南(第2版)[M].北京:科学教育出版社,1998.343.
  • 3Bonfant M, Tarerna S, Salmona M, et al. p21wan-derived peptides linked to an internalization peptide inhibit human cancer cell growth[J]. Cancer Res, 1997, 57 (8): 1442-1446.
  • 4Harper JW, Adam GR, Wei N, et al . The p21 cdk -interacting protein cip1 is a potent inhibitor of G1 cyclin -dependent kinases [J]. Cell, 1993, 75 (4): 805-816.
  • 5EI-Deriry WS, Tokino T, Velculescu VE, et al . WAF1, a potential mediator of p53 tumor suppression [J]. Cell, 1993,75 (4): 817-825.
  • 6Chen QY, Cipriano SC, Arenkiel JM, et al . Tumor suppression by p21waf1 [J]. Cancer Res, 1995, 55 (20): 4536.
  • 7Luo Y, Hurwitz J, Massague J. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21 [J].Nature, 1995, 375 (6527): 159-161.
  • 8Chen J, Jackson PK, Kirschnor MW, et al. Separate domains of p21 involyed in the inhibition of cdk kinase and PCNA [J].Nature, 1995, 374 (6520): 306-388.
  • 9刘青,万敏,卫红飞,吴秀丽,张培因,王燕媚,杨翰仪,王丽颖.人酸性成纤维细胞生长因子在大肠杆菌的高效表达[J].吉林大学学报(医学版),2004,30(1):1-5. 被引量:5

二级参考文献10

  • 1[1]Cuevas P,Carceller F,Munoz-Willery I,et al.Intravenous fibroblast growth factor penetrates the blood-brain barrier and protects hippocampal aganinst ischemia-reperfusion injury [J].Surg Neurol,1998,49:77-83.
  • 2[2]Cuevas P,Carceller F,Redondo-Horcajo M,et al.Systemic administration of acidic fibroblast growth factor ameliorates the ischemic injury of the retina in rats [J].Neurosci Lett,1998,255:1-4.
  • 3[3]Cuevas P,Carceller F,Cuevas P.Spasmolytic effect of acidic fibroblast growth factor in early cerebral vasospasm in the rat [J].SurgNeurol,1998,49:176-184.
  • 4[4]Mocchetti I,Wrathall JR.Neurotrophic factors in central nervous system trauma [J].J Neurotrauma,1995,12(5):853-870.
  • 5[5]Mellin TN,Cashen DE,Ronan JJ,et al.Acidic fibroblast growth factor accelerates dermal wound healing in diabetic mice[J].J Invest Dermatol,1995,104(5):850-855.
  • 6[6]Lee YS,Baratta J,Yu J,et al.AFGF promotes axonal growth in rat spinal cord organotypic slice co-cultures [J].J Neurotrauma,2002,19(3):357-367.
  • 7[7]Buehler A,Martire A,Strohm C,et al.Angiogenesisindependent cardioprotection in FGF-1 transgenic mice [J].Cardiovasc Res,2002,55(4):768-777.
  • 8[8]Studier FW,Moffatt BA.Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes [J].J Mol Biol,1986,189(1):113-130.
  • 9[9]Rosenberg AH,Lade BN,Chui DS,et al.Vectors for selective expression of cloned DNAs by T7 RNA polymerase [J].Gene,1987,56(1):125-135.
  • 10[10]Studier FW,Rosenberg AH,Dunn J J,et al.Use of T7 RNA polymerase to direct expression of cloned genes [J].Meth Enzymol,1990,185:60-89.

共引文献16

同被引文献7

  • 1Roubey RS.Immunology of the antiphodpholipid antibody syndrome[J].Arthritis Rheum,1996,39:1444-1454.
  • 2McNeil HP,Simpson RJ,Chesterman CN,et al.Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation:β2GP1glycoprotein 1 (apolipoprotein H)[J].Proc Natl Acad Sci USA,1990,87:4120-4124.
  • 3Michael-Iverson G,Reddel S,Victoria EJ,et al.Use of single point mutations in domain I of β2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies[J].J Immunol,2002,169:7097-7103.
  • 4George J,Gilburd B,Hojnik M,et al.Target recognition of β2-glycoprotein Ⅰ (β2GP Ⅰ)-dependent aqnticardiolipin antibodies:Evidence for involvement of the fourth domain of β2GPⅠ in antibody binding[J].J Immunol,1998,160:3917-3923.
  • 5Wang MX,Kandiah DA,Ichikawa K,et al.Epitope specificity of monoclonal anti-β2 glycoprotein 1 antibodies derived from patients with the antiphospholipid syndrome[J].J Immunol,1995,155:1629-1636.
  • 6萨穆布鲁斯J,弗里奇EF,曼尼阿蒂斯T.分子克隆实验指南[M].北京:科学出版社,1996:845-849.
  • 7Michaelqverson G,Victoria EJ,Cockerill KA,et al.Advances in understanding what we measure when detecting anticardiolipin autoantibodies[J].Clinica Chimica Acta,2004,343:37-44.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部